This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: University Court of the University of St. Andrews, University of Dundee. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2013-2015
Title: The Innovative Contributions of Jonathan James Hollick
Introduction
Jonathan James Hollick is an accomplished inventor based in Inchture, GB. With two patents to his name, Hollick has made significant contributions to the field of medical innovation, particularly in the treatment of hyperproliferative diseases, including cancer.
Latest Patents
Hollick's latest patents focus on P53 activating compounds. These compounds are designed to activate the p53 response, which plays a crucial role in regulating the cell cycle and preventing tumor formation. The utility of these compounds extends beyond cancer treatment, with potential applications in other diseases and conditions involving sirtuin function.
Career Highlights
Throughout his career, Hollick has collaborated with renowned institutions such as the University Court of the University of Dundee and the University Court of the University of St. Andrews. His work is pivotal in advancing our understanding and treatment of serious health conditions.
Collaborations
In his professional journey, Hollick has had the opportunity to work alongside notable colleagues, including Sonia Lain and David Phillip Lane. Their collective expertise has undoubtedly enriched the research and innovations initiated under Hollick's guidance.
Conclusion
Jonathan James Hollick stands out as a visionary inventor committed to tackling some of the most challenging health issues of our time. His patents on P53 activating compounds represent not only his innovative spirit but also a hopeful stride towards significant advancements in medical treatment. Through collaboration and relentless pursuit of knowledge, Hollick continues to inspire the field of biomedical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile